Dr. William Irvin, MD
Claim this profileBon Secours Cancer Institute Richmond
Area of expertise
Lung Cancer
William Irvin, MD has run 3 trials for Lung Cancer. Some of their research focus areas include:
Non-Small Cell Lung Cancer
William Irvin, MD has run 2 trials for Non-Small Cell Lung Cancer. Some of their research focus areas include:
Affiliated Hospitals
Bon Secours Cancer Institute Richmond
Bon Secours Richmond
Clinical Trials William Irvin, MD is currently running
Fianlimab + Cemiplimab
for Non-Small Cell Lung Cancer
This trial is testing a new drug combination for patients with advanced lung cancer. It aims to see if using two drugs together is more effective than one alone. The study also looks at side effects, how the drugs are processed in the body, and their impact on quality of life.
Recruiting
0 awards
Phase 2 & 3
Fianlimab + Cemiplimab + Chemotherapy
for Non-Small Cell Lung Cancer
This trial is testing a new drug called fianlimab with cemiplimab and chemotherapy in patients with advanced lung cancer. The goal is to see if this combination is more effective than current treatments. The new drugs help the immune system fight cancer, while chemotherapy attacks the cancer cells directly.
Recruiting
0 awards
Phase 2 & 3
6 criteria
More about William Irvin, MD
Clinical Trial Related
2 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments William Irvin, MD has experience with
- Pemetrexed
- Cemiplimab
- Fianlimab
- Placebo
- Carboplatin
- N-803
Breakdown of trials William Irvin, MD has run
Lung Cancer
Non-Small Cell Lung Cancer
Pancreatic Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does William Irvin, MD specialize in?
William Irvin, MD focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is William Irvin, MD currently recruiting for clinical trials?
Yes, William Irvin, MD is currently recruiting for 2 clinical trials in Midlothian Virginia. If you're interested in participating, you should apply.
Are there any treatments that William Irvin, MD has studied deeply?
Yes, William Irvin, MD has studied treatments such as Pemetrexed, Cemiplimab, Fianlimab.
What is the best way to schedule an appointment with William Irvin, MD?
Apply for one of the trials that William Irvin, MD is conducting.
What is the office address of William Irvin, MD?
The office of William Irvin, MD is located at: Bon Secours Cancer Institute Richmond, Midlothian, Virginia 23114 United States. This is the address for their practice at the Bon Secours Cancer Institute Richmond.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.